Home › Parkinson's Disease › Oklahoma › Tulsa
Parkinson's Disease clinical trials in Tulsa, OK
4 studies for Parkinson's Disease are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
- The Movement Disorder Clinic of Oklahoma, Tulsa
A Study of Buntanetap in Participants With PD
RecruitingPhase 2/3
- The Movement Disorder Clinic of Oklahoma, Tulsa
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- The Movement Disorder Clinic of Oklahoma, Tulsa
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
RecruitingPhase 4
- The Movement Disorder Clinic of Oklahoma, Tulsa
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Farmington Hills, MI13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
Other studies in Tulsa
- Heart Failure10 studies
- Overweight6 studies
- Obesity5 studies
- Melanoma5 studies
- Ischemic Stroke5 studies
- COPD4 studies
- Aortic Valve Stenosis4 studies
- Cervical Cancer4 studies
- Breast Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Depression4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.